Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,679 | 60,574 | 127,106 | 148,011 | 131,973 |
| Marketable Securities | 821,365 | 876,295 | 907,405 | 961,245 | 1,059,014 |
| TOTAL | $928,383 | $973,575 | $1,064,137 | $1,142,884 | $1,224,062 |
| Non-Current Assets | |||||
| PPE Net | 48,077 | 46,863 | 45,589 | 48,101 | 39,821 |
| Investments And Advances | 450,994 | 490,723 | 0 | 7,905 | 0 |
| Other Non-Current Assets | 75,111 | 69,930 | 44,191 | 37,887 | 41,851 |
| TOTAL | $574,182 | $607,516 | $89,780 | $93,893 | $81,672 |
| Total Assets | $1,502,565 | $1,581,091 | $1,153,917 | $1,236,777 | $1,305,734 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,936 | 11,855 | 9,483 | 1,182 | 8,520 |
| Accrued Expenses | 33,039 | 42,662 | 68,499 | 36,286 | 35,986 |
| Other current liabilities | 19,787 | 20,553 | N/A | 26,698 | 18,077 |
| TOTAL | $74,533 | $82,582 | $77,982 | $71,180 | $69,357 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 40,981 | 43,034 | 44,981 | 47,266 | 49,552 |
| TOTAL | $40,981 | $43,034 | $44,981 | $47,266 | $49,552 |
| Total Liabilities | $115,514 | $125,616 | $122,963 | $118,446 | $118,909 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 143,165 | 142,609 | 139,160 | 138,197 | 137,422 |
| Common Shares | 1,757 | 1,751 | 1,711 | 1,707 | 1,700 |
| Retained earnings | -1,317,039 | -1,218,013 | -1,116,211 | -996,738 | -897,385 |
| Other shareholders' equity | -2,659 | -1,296 | 643 | -651 | -1,441 |
| TOTAL | $1,387,051 | $1,455,475 | $1,030,954 | $1,118,331 | $1,186,825 |
| Total Liabilities And Equity | $1,502,565 | $1,581,091 | $1,153,917 | $1,236,777 | $1,305,734 |